News from cepheid A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 04, 2014, 07:00 ET

Cepheid Recognized as Innovation Leader

 Cepheid (NASDAQ: CPHD) today announced that it has been named to Forbes magazine's list of the World's Most Innovative Growth Companies,...

Sep 03, 2014, 07:00 ET

Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections

 Cepheid (NASDAQ: CPHD) today announced the release of Xpert® TV, an on-demand molecular test for rapid, accurate and reproducible...

Sep 02, 2014, 07:00 ET
Influenza: Evolution in Action. (PRNewsFoto/Cepheid)

Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection

Cepheid (NASDAQ: CPHD) announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable...

Jul 31, 2014, 16:05 ET

Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...

Jul 30, 2014, 16:05 ET

Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement

 Cepheid (Nasdaq: CPHD) today announced that its group purchasing contract with Premier will end on September 30, 2014.  Customers...

Jul 29, 2014, 07:00 ET

Cepheid Reports China Installed Base Close To 1,000 GeneXpert® Systems

With the recent completion of a record shipment of 774 GeneXpert systems to a single country in one quarter, Cepheid (Nasdaq: CPHD) today applauded...

Jul 17, 2014, 16:05 ET

Cepheid Reports 2014 Second Quarter Results

 Cepheid (Nasdaq: CPHD) today reported revenues for the second quarter of 2014 of $116.5 million, representing growth of 21% from $96.0 million...

Jul 03, 2014, 13:05 ET

Cepheid Schedules 2014 Second Quarter Results Announcement And Webcast

 Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2014 second quarter ended June 30, 2014 on Thursday, July...

Jun 19, 2014, 07:00 ET

Cepheid And Leading Pharmaceutical Companies Partner On A Diagnostic Test To Help Tackle Multidrug-Resistant Bacterial Infections

 Cepheid (Nasdaq: CPHD) today announced a new collaboration with AstraZeneca, Cubist Pharmaceuticals, Inc., and GSK intended to promote...

Jun 16, 2014, 07:00 ET

Cepheid Announces European Release of Xpert Carba-R, a Molecular Test for Rapid and Accurate Detection of Carbapenemase-producing Gram-negative Bacteria

Cepheid (NASDAQ: CPHD) today announced the release of Xpert® Carba-R, an on-demand molecular test for rapid and accurate detection of...

Jun 09, 2014, 16:05 ET

Cepheid Welcomes Executive Vice President Of International Commercial Operations

Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. Peter Farrell to the position of Executive Vice President of International...

May 22, 2014, 16:05 ET

Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...

Apr 29, 2014, 16:05 ET

Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...

Apr 17, 2014, 16:05 ET

Cepheid Reports 2014 First Quarter Results

 Cepheid (Nasdaq: CPHD) today reported revenues for the first quarter of 2014 of $106.9 million, representing growth of 16% from $91.9 million...

Apr 10, 2014, 07:00 ET

Cepheid Announces European Release of Xpert Norovirus, the First On-Demand Molecular Test for Detection of Norovirus

Cepheid (NASDAQ: CPHD) today announced the release of Xpert® Norovirus, a qualitative in vitro diagnostic test for rapid identification and...

Apr 03, 2014, 16:05 ET

Cepheid Schedules 2014 First Quarter Results Announcement and Webcast

Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2014 first quarter ended March 31, 2014 on Thursday, April 17,...

Apr 02, 2014, 07:00 ET

Cepheid Announces European Release of Xpert HPV, a 60-Minute Test for Cervical Cancer-Related Human Papillomaviruses

Cepheid (NASDAQ: CPHD) today announced the release of Xpert® HPV, a 60-minute test for cervical cancer-related human papillomaviruses to be...

Mar 21, 2014, 07:00 ET

In Recognition of World TB Day 2014, Cepheid and American Lung Association to Ring the NASDAQ Stock Market Opening Bell

 Cepheid (Nasdaq: CPHD) today announced that James Post, Executive Vice President, North America Commercial Operations for Cepheid,...

Mar 20, 2014, 07:00 ET

Cepheid and American Lung Association to Reveal Winner of the 'Ride Against TB' Bike at 2nd Annual New York City TB Walk

Cepheid (Nasdaq: CPHD) today announced that the winner of the Ride Against TB bike, a prize in the campaign to benefit the American Lung...

Feb 10, 2014, 16:05 ET

Cepheid Announces Closing Of $345 Million Of 1.25% Convertible Senior Notes Due 2021

 Cepheid (Nasdaq: CPHD) today announced the closing of its offering of $345 million aggregate principal amount of 1.25% Convertible Senior...